News | August 13, 2023
Panacea Biotec posts Q1 FY24 consolidated PAT at Rs. 10.98 Cr
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023
Natural Capsules Ltd. has reported total income of Rs. 37.87 crores during the period ended June 30, 2023
Abbott India has reported total income of Rs. 1535 crores during the period ended June 30, 2023
IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
